Sanofi's experimental drug ataciguat has shown promise in reducing the progression of aortic valve stenosis in clinical trials, potentially delaying the need for surgical valve replacement. With ...
Tribune Content Agency on MSN2h
The Medicine Cabinet: Ask the Harvard Experts: Why an aortic valve can narrow and impede blood flowQ: My doctor heard a new heart murmur and suspected I have a narrowed valve due to aortic stenosis. I feel fine. Why did this ...
Ataciguat, a new drug being studied for aortic valve stenosis, shows promise in slowing disease progression and reducing the ...
Discover how recent advancements in cardiovascular medicine, including TAVI and TEER, are revolutionizing heart disease ...
The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the ...
Using a small catheter inserted in the leg, the TriClip is delivered to the heart and works by clipping together a portion of the leaflets of the tricuspid valve.
The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback